Anya Biopharm Inc. (TPEX:7776)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Pharmaceuticals	16.27M	21.60M	2.32M	2.50M
Total	16.27M	21.60M	2.32M	2.50M

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Europe	849.00K	834.00K	986.00K	781.00K
Taiwan	571.00K	571.00K	1.33M	1.72M
Asia	14.85M	20.19M	-	-
Total	16.27M	21.60M	2.32M	2.50M

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 2, 2026

Data Sources Report a data error